Integrating Pharmacogenetic Data into Clinical Decision Support
Author Information
Author(s): Kimberly J. Newsom, Bradley Hall, Katherine A. Martinez, Scott Nelson, Petr Starostik, Khoa Nguyen
Primary Institution: University of Florida
Hypothesis
Can the integration of pharmacogenetic data into electronic health records improve clinical decision-making?
Conclusion
The integration of pharmacogenetic data into the Genomic Module significantly enhances clinical decision support and patient care.
Supporting Evidence
- The integration of genomic indicators allows for better interpretation of genetic data.
- Over 11,000 patient results were transitioned to the new system, improving clinical decision-making.
- The study demonstrated a 112% increase in alerts interacted with by providers after implementation.
Takeaway
This study shows that using genetic information in healthcare can help doctors make better decisions for their patients.
Methodology
The study involved integrating pharmacogenetic data into Epic's Genomic Module using HL7 standards to enhance clinical decision support.
Limitations
Challenges included integrating data from third-party instruments and limitations in interpreting complex gene-drug interactions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website